Multi-small molecule conjugations as new targeted delivery carriers for tumor therapy

References

• LlinasAGlenRCGoodmanJMSolubility challenge: can you predict solubilities of thirty-two molecules using a database of one hundred reliable measurementsJ Chem Inf Model20084812891230318624401
   PubMed Web of Science ®Google Scholar
• WenlockMCAustinRPBartonPProdrug approaches for enhancing the bioavailability of drugs with low solubilityJ Med Chem2003461250125612646035
   PubMed Web of Science ®Google Scholar
• WilliamsHDTrevaskisNLCharmanSAStrategies to address low drug solubility in discovery and developmentPharmacol Rev20136531549923383426
   PubMed Web of Science ®Google Scholar
• KimEJBhuniyaSLeeHAn activatable prodrug for the treatment of metastatic tumorsJ Am Chem Soc201413613881394
   Web of Science ®Google Scholar
• SinglaAKGargAAggarwalDPaclitaxel and its formulationsInt J Pharm200223517919211879753
   PubMed Web of Science ®Google Scholar
• DorrRTPharmacology and toxicology of Cremophor EL diluentAnn Pharmacother199428S11S147915152
   PubMed Web of Science ®Google Scholar
• HolvoetCVander HeydenYLoriesGPlaizier-VercammenJPreparation and evaluation of paclitaxel-containing liposomesPharmazie2007212613217341033
   PubMedGoogle Scholar
• DuongHHYungLYSynergistic co-delivery of doxorubicin and paclitaxel using multi-functional micelles for cancer treatmentInt J Pharm20135448649523792465
   PubMedGoogle Scholar
• ShahinMAhmedSKaurKLavasanifarADecoration of polymeric micelles with cancer-specific peptide ligands for active targeting of paclitaxelBiomaterials2011325123513321501865
   PubMed Web of Science ®Google Scholar
• YezhelyevMYacoubRO’ReganRInorganic nanoparticles for predictive oncology of breast cancerNanomedicine (Lond)200948310319093898
   PubMed Web of Science ®Google Scholar
• PaálKMüllerJHegedûsLHigh affinity binding of paclitaxel to human serum albuminEur J Biochem20012682187219111277943
   PubMedGoogle Scholar
• WangHZhaoYWuYEnhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticlesBiomaterials2011328281829021807411
   PubMed Web of Science ®Google Scholar
• GuptaNHatoumHDyGKFirst line treatment of advanced non-small-cell lung cancer-specific focus on albumin bound paclitaxelInt J Nanomedicine2014920922124399877
   PubMed Web of Science ®Google Scholar
• WohlARMichelARKalscheuerSMacoskoCWPanyamJHoyeTRSilicate esters of paclitaxel and docetaxel: synthesis, hydrophobicity, hydrolytic stability, cytotoxicity, and prodrug potentialJ Med Chem2014572368237924564494
   PubMed Web of Science ®Google Scholar
• MaPMumperRJPaclitaxel nano-delivery systems: a comprehensive reviewJ Nanomed Nanotechnol201318100016424163786
   PubMedGoogle Scholar
• ShanLCuiSDuCA paclitaxel-conjugated adenovirus vector for targeted drug delivery for tumor therapyBiomaterials20123314616221959006
   PubMed Web of Science ®Google Scholar
• HasabelnabySGoudahAAgarwalHKabd AllaMSTjarksWSynthesis, chemical and enzymatic hydrolysis, and aqueous solubility of amino acid ester prodrugs of 3-carboranyl thymidine analogs for boron neutron capture therapy of brain tumorsEur J Med Chem20125532533422889558
   PubMed Web of Science ®Google Scholar
• AroteRBHwangSKLimHTThe therapeutic efficiency of FP-PEA/TAM67 gene complexese via folate receptor-mediated endocytosis in a xenograft mice modelBiomaterials2010312435244520022105
   PubMed Web of Science ®Google Scholar
• LeanmonCPLowPSDelivery of macromolecules into living cells: a method that exploits folate receptor endocytosisProc Natl Acad Sci U S A199188557255762062838
   PubMed Web of Science ®Google Scholar
• JhaveriMSRaitASChungKNTrepelJBChangEHAntisense oligonucleotides targeted to the human folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatmentMol Cancer Ther200431505151215634643
   PubMed Web of Science ®Google Scholar
• WuMGunningWRatnamMExpression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervixCancer Epidemiol Biomarkers Prev1999877578210498396
   PubMed Web of Science ®Google Scholar
• ShanLXueJGuoJQianZAchilefuSGuYImproved targeting of ligand-modified adenovirus as a new near infrared fluorescence tumor imaging probeBioconjug Chem20112256758121401110
   PubMed Web of Science ®Google Scholar
• ZhangJChenHXuLGuYThe targeted behavior of thermally responsive nanohydrogel evaluated by NIR system in mouse modelJ Control Release2008131344018691619
   PubMed Web of Science ®Google Scholar
• AmaechiBTRamalingamKEvaluation of fluorescence imaging with reflectance enhancement technology for early caries detectionAm J Dent20142711111625000670
   PubMed Web of Science ®Google Scholar
• MondalSBGaoSZhuNLiangRGruevVAchilefuSReal-time fluorescence image-guided oncologic surgeryAdv Cancer Res201412417121125287689
   PubMed Web of Science ®Google Scholar
• GreenwaldRBPendriABolikalDHighly water soluble Taxol derivatives: 7-polyethylene glycol carbamates and carbonatesJ Org Chem199560331336
   Web of Science ®Google Scholar
• YoshidaMMaeharaYSugimachiKMST-16, a novel bis-dioxopiperazine anticancer agent, ameliorates doxorubicin-induced acute toxicity while maintaining antitumor efficacyClin Cancer Res199954295430010632373
   PubMed Web of Science ®Google Scholar
• GuillemardVSaragoviHUTaxane-antibody conjugates afford potent cytotoxicity, enhanced solubility, and tumor target selectivityCancer Res20016169469911212270
   PubMed Web of Science ®Google Scholar
• BoztasAOKarakuzuOGalanteGSynergistic interaction of paclitaxel and curcumin with cyclodextrin polymer complexation in human cancer cellsMol Pharm2013107683
   Google Scholar
• TsukiyamaITakeuchiMAbeFDe-alcoholization of paclitaxel injection for clinical applicationAnticancer Res2011314339434622199299
   PubMed Web of Science ®Google Scholar
• BandaraNAHansenMJLowPSEffect of receptor occupancy on folate receptor internalizationMol Pharm2014115666
   Google Scholar